Besins Healthcare (UK - search results

besins healthcare - micronised progesterone - capsules, soft - 100 mg - adjunctive use with estrogen in post-menopausal women with an intact uterus. (hrt)

Ireland - English - HPRA (Health Products Regulatory Authority)

testosterone besins 1000 mg/4 ml solution for injection

besins healthcare ireland limited - testosterone undecanoate - solution for injection - testosterone

Australia - English - Department of Health (Therapeutic Goods Administration)

slinda drospirenone 4 mg tablet blister pack

besins healthcare australia pty ltd - drospirenone, quantity: 4 mg - tablet, film coated - excipient ingredients: lactose monohydrate; maize starch; povidone; colloidal anhydrous silica; magnesium stearate; hypromellose; triacetin; polysorbate 80; titanium dioxide; indigo carmine aluminium lake; iron oxide yellow - contraception

Australia - English - Department of Health (Therapeutic Goods Administration)

utrogestan 200 progesterone 200 mg soft vaginal capsule blister pack

besins healthcare australia pty ltd - progesterone, quantity: 200 mg - pessary, shell - excipient ingredients: glycerol; lecithin; titanium dioxide; gelatin; purified water; sunflower oil - luteal phase support ? luteal support of assisted reproductive technology (art) cycles,support during pregnancy ? prevention of preterm birth in women with singleton pregnancy who have a short cervix (midtrimester sonographic cervix less than or equal to 25 mm) and/or a history of spontaneous preterm birth. ? treatment of unexplained threatened miscarriage in women with bleeding in the current pregnancy and a history of at least three or more previous miscarriages. use in women with less than three miscarriages may be warranted in those with reduced chances of future pregnancy such as those undergoing ivf treatment with limited viable egg and/or embryo availability or advanced fertility age. however, the benefit of treatment in clinical trials was limited to women with three or more miscarriages. (see section 5 pharmacological properties; clinical trials; threatened unexplained miscarriage)